These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15317034)

  • 1. Clinical review procedures for the Antiretroviral Pregnancy Registry.
    Scheuerle A; Covington D
    Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):529-36. PubMed ID: 15317034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing teratogenicity of antiretroviral drugs: monitoring and analysis plan of the Antiretroviral Pregnancy Registry.
    Covington DL; Tilson H; Elder J; Doi P
    Pharmacoepidemiol Drug Saf; 2004 Aug; 13(8):537-45. PubMed ID: 15317035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of selected characteristics of pregnancy drug registries.
    Honein MA; Paulozzi LJ; Cragan JD; Correa A
    Teratology; 1999 Dec; 60(6):356-64. PubMed ID: 10590397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the risk of birth defects associated with antiretroviral exposure during pregnancy.
    Watts DH; Covington DL; Beckerman K; Garcia P; Scheuerle A; Dominguez K; Ross B; Sacks S; Chavers S; Tilson H
    Am J Obstet Gynecol; 2004 Sep; 191(3):985-92. PubMed ID: 15467577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registry.
    Scheuerle A; Tilson H
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):465-75. PubMed ID: 12426931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal asthma, asthma medication use, and the risk of congenital heart defects.
    Lin S; Herdt-Losavio M; Gensburg L; Marshall E; Druschel C
    Birth Defects Res A Clin Mol Teratol; 2009 Feb; 85(2):161-8. PubMed ID: 19067406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Including prenatal diagnoses in birth defects monitoring: Experience of the Metropolitan Atlanta Congenital Defects Program.
    Cragan JD; Gilboa SM
    Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):20-9. PubMed ID: 19089857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Antiretroviral Pregnancy Registry: Three decades of prospective monitoring for birth defects.
    Albano JD; Scheuerle AE; Watts DH; Beckerman KP; Mofenson LM; Pikis A; Vannappagari V; Seekins D; Cook TS; Tilson H;
    Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5801. PubMed ID: 38798093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation.
    Armenti VT; Daller JA; Constantinescu S; Silva P; Radomski JS; Moritz MJ; Gaughan WJ; McGrory CH; Coscia LA
    Clin Transpl; 2006; ():57-70. PubMed ID: 18368705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.
    Colvin J; Bower C; Dickinson JE; Sokol J
    Pediatrics; 2005 Sep; 116(3):e356-63. PubMed ID: 16140678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
    Cooper WO
    J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiretrovirals in pregnancy registry: a fifteenth anniversary celebration.
    Tilson HH; Doi PA; Covington DL; Parker A; Shields K; White A
    Obstet Gynecol Surv; 2007 Feb; 62(2):137-48. PubMed ID: 17229330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental epidemiology at the Medical Birth Registry of Norway; strengths and limitations.
    Lie RT
    Cent Eur J Public Health; 1997 Jun; 5(2):57-9. PubMed ID: 9208158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical exposures during pregnancy and congenital cardiovascular malformations.
    Judge CM; Chasan-Taber L; Gensburg L; Nasca PC; Marshall EG
    Paediatr Perinat Epidemiol; 2004 Sep; 18(5):352-60. PubMed ID: 15367322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy registries: strengths, weaknesses, and bias interpretation of pregnancy registry data.
    Cunnington M; Messenheimer J
    Int Rev Neurobiol; 2008; 83():283-304. PubMed ID: 18929089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurements of birth defect prevalence: which is most useful as a comparator group for pharmaceutical pregnancy registries?
    Scheuerle A; Vannappagari VX; Miller MK
    Birth Defects Res A Clin Mol Teratol; 2009 Jul; 85(7):611-20. PubMed ID: 19215016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal smoking and congenital heart defects.
    Malik S; Cleves MA; Honein MA; Romitti PA; Botto LD; Yang S; Hobbs CA;
    Pediatrics; 2008 Apr; 121(4):e810-6. PubMed ID: 18381510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are girls more susceptible to the effects of prenatal exposure to tobacco smoke on asthma?
    Jaakkola JJ; Gissler M
    Epidemiology; 2007 Sep; 18(5):573-6. PubMed ID: 17700244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using active birth defects surveillance programs to supplement data on fetal death reports: improving surveillance data on stillbirths.
    Duke W; Williams L; Correa A
    Birth Defects Res A Clin Mol Teratol; 2008 Nov; 82(11):799-804. PubMed ID: 18985684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.